Posted by Michael Wonder on 27 Jun 2024
ICER publishes final evidence report on treatment for post-traumatic stress disorder
27 June 2024 - Independent appraisal committee voted that current evidence is not adequate to demonstrate superior net health benefits for MDMA-AP compared to short-term trauma-focused psychotherapies.
The ICER today released a final evidence report assessing the comparative clinical effectiveness and value of MDMA-assisted psychotherapy (MDMA-AP; Lykos Therapeutics) for the treatment of post-traumatic stress disorder.
